References
- Joshi HN, Tejwani RW, Davidovich M, et al. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int J Pharm 2004;269:251–8
- Yadav PS, Kumar V, Singh UP, et al. Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and D-mannitol. Saudi Pharm J 2013;21:77--84
- Yoshida T, Kurimoto I, Yoshihara K, et al. Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: evaluation of solid dispersion formulations. Int J Pharm 2012;428:18–24
- Verheyen S, Blaton N, Kinget R, Van den Mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 2002;249:45–58
- Konno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm 2008;70:493–9
- Papadimitriou SA, Barmpalexis P, Karavas E, Bikiaris DN. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I. Eur J Pharm Biopharm 2012;82:175–86
- Kiyohara H, Ichino C, Kawamura Y, et al. Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth. J Nat Med 2012;66:55–61
- Huang XW, Liu RT, Lü QJ. Patchouli alcohol on memory impairment induced by scopolamine learning and memory function in mice. Zhong Cao Yao 2009;40:1431--3
- Li YC, Xian YF, Ip SP, et al. Anti-inflammatory activity of patchouli alcohol isolated from Pogostemonis Herba in animal models. Fitoterapia 2011;82:1295–301
- Weide M, Schloesser A, Bockmuehl D, et al. Agents against microorganisms, containing patchouli oil, patchouli alcohol and/or the derivatives thereof. US patent US20060134239A1; 2006
- Xian YF, Li YC, Ip SP, et al. Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages. Exp Ther Med 2011;2:545–50
- You X, Wang R, Tang W, et al. Self-microemulsifying drug delivery system of patchoulic alcohol to improve oral bioavailability in rats. Zhongguo Zhong Yao Za Zhi 2010;35:694–8
- Srinarong P, Faber JH, Visser MR, et al. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm 2009;73:154–61
- Vijaya Kumar SG, Mishra DN. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000. Yakugaku Zasshi 2006;126:657–64
- Shen Y, Lu F, Hou J, et al. Incorporation of paclitaxel solid dispersions with poloxamer188 or polyethylene glycol to tune drug release from poly(-caprolactone) films. Drug Dev Ind Pharm 2013;39:1187–96
- Yin LF, Huang SJ, Zhu CL, et al. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Drug Dev Ind Pharm 2012;38:1371–80
- Bley H, Fussnegger B, Bodmeier R. Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm 2010;390:165–73
- Weuts I, Kempen D, Verreck G, et al. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur J Pharm Biopharm 2005;59:119–26
- Rabasco AM, Ginés JM, Fernández Arévalo M, Holgado MA. Dissolution rate of diazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 1991;67:201--5
- Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm 1999;181:143–51
- Quinteros DA, Rigo VR, Kairuz AF, et al. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. Eur J Pharm Sci 2008;33:72–9
- Rowe RC, Sheskey PJ, Owen SnC, American Pharmacists Association. Handbook of pharmaceutical excipients. 5th ed. In: Raymond CR, Paul JS, Siân CO, eds. London; Greyslake, IL; Washington, DC: Pharmaceutical Press; American Pharmacists Association; 2006:xxi, 918 p
- Mallick S, Sahoo A, Mitra SS. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions. Boll Chim Farm 2003;142:180–6
- Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, et al. Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev Ind Pharm 2007;33:45–56
- Lai XP, Su ZR, Chen JN, et al. Use of patchouli alcohol in preparation of drug against. Helicobacter pylori. China patent CN101485647A; 2013
- Save T, Venkitachalam P. Studies on solid dispersions of nifedipine. Drug Dev Ind Pharmacy 1992;18:1663–79
- Gines JM, Arias MJ, Moyano JR, SanchezSoto PJ. Thermal investigation of crystallization of polyethylene glycols in solid dispersions containing oxazepam. Int J Pharmaceut 1996;143:247–53
- Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharmaceut Sci 1999;88:1058–66
- Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharmaceut Biopharmaceut 2000;50:47–60
- Ayad MH, Bonnet B, Quinton J, et al. Amorphous solid dispersion successfully improved oral exposure of ADX71943 in support of toxicology studies. Drug Dev Ind Pharm 2013;39:1300–5
- Lalkshman JP, Cao Y, Kowalski J, Serajuddin ATM. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharmaceut 2008;5:994–1002